Roy, P., Islam, R., Saha, D., Gogoi, M., Mishra, D. K., Arora, N., . . . Saha, V. (2019). Efficacy and safety of a bortezomib and reduced intensity cytarabine based protocol, TMC ALLR1, for relapsed childhood ALL in India. Br J Haematol.
Citação norma ChicagoRoy, Prakriti, Rubina Islam, Debparna Saha, Manash Gogoi, Deepak Kumar Mishra, Neeraj Arora, Mayur Parihar, Shekhar Krishnan, and Vaskar Saha. "Efficacy and Safety of a Bortezomib and Reduced Intensity Cytarabine Based Protocol, TMC ALLR1, for Relapsed Childhood ALL in India." Br J Haematol 2019.
Citação norma MLARoy, Prakriti, et al. "Efficacy and Safety of a Bortezomib and Reduced Intensity Cytarabine Based Protocol, TMC ALLR1, for Relapsed Childhood ALL in India." Br J Haematol 2019.